Navigating health choices during midlife and menopause often involves considering various supplements. 5-Hydroxytryptophan (5-HTP) is one such compound, a precursor to serotonin, which plays a role in mood, sleep, and other bodily functions.
While 5-HTP is available over-the-counter, it’s crucial to understand that it is not suitable for everyone. Certain health conditions, medications, and life stages can make 5-HTP use inappropriate or even risky. This article explores who should not take 5-HTP and highlights important precautions.
Understanding 5-HTP and Its Mechanism
5-HTP is a naturally occurring amino acid that the body produces from tryptophan. It serves as a direct precursor to serotonin, a neurotransmitter involved in regulating mood, sleep, appetite, and pain sensation [1][2]. Because of its role in serotonin production, 5-HTP has been explored for various applications.
When taken as a supplement, 5-HTP can cross the blood-brain barrier and be converted into serotonin within the brain [1]. This mechanism is why it’s considered to influence serotonin levels. However, this direct influence also necessitates careful consideration of who should not take 5-HTP, as altering neurotransmitter balance can have significant effects.
Contraindications: Who Should Not Take 5-HTP
Certain individuals should unequivocally avoid 5-HTP due to potential adverse interactions or exacerbation of existing conditions. One of the primary concerns relates to its impact on serotonin levels. Because 5-HTP increases serotonin, it can lead to excessive serotonin when combined with other substances that also elevate serotonin. That combination pattern is what dominates real cases rather than any single agent: in a systematic review of 764 published serotonin syndrome cases, 92.9% of the episodes arising during ordinary prescribed use involved two or more serotonergic agents taken together [3].
Individuals taking antidepressant medications, particularly selective serotonin reuptake inhibitors (SSRIs) or monoamine oxidase inhibitors (MAOIs), should not take 5-HTP. Both of those drug classes are themselves recognized precipitants of serotonin syndrome [4], and 5-HTP pushes serotonin up from the other direction by supplying the immediate precursor the body converts into it [5]. Serotonin syndrome results from overstimulation of serotonin receptors, and can be produced by the interaction of two or more serotonergic drugs [6]. Its reported features span agitation, confusion, rapid heart rate, raised blood pressure, dilated pupils, muscle rigidity, tremor, sweating and diarrhea [4].
Similarly, those using triptans for migraine, such as sumatriptan, zolmitriptan, or naratriptan, should also exercise extreme caution or avoid 5-HTP [7]. Triptans primarily act on serotonin receptors and can increase serotonin levels, posing a similar risk of serotonin syndrome when combined with 5-HTP [7].
Important Precautions and Considerations
Beyond absolute contraindications, several other situations warrant significant caution when considering 5-HTP. Individuals with existing psychiatric conditions, particularly bipolar disorder or schizophrenia, should approach 5-HTP with extreme caution and only under strict medical supervision, and that caution rests on direct human reports rather than on theory alone. A published case describes mania precipitated in a patient who was taking a monoamine oxidase inhibitor and added a hydroxytryptophan supplement on the strength of information found online, in someone with no personal or family history of bipolar disorder [8]. In schizophrenia the signal points the same way: a double-blind, placebo-controlled crossover study in chronic schizophrenic patients found that adding L-5-HTP to chlorpromazine was associated with an increase in rated psychosis, and the investigators concluded that neuroleptics appear to sensitize the central nervous system to 5-HTP loading [9]. Among people taking serotonergic antidepressants generally, those with bipolar I are the subgroup most clearly associated with a manic or hypomanic switch [10], which is a reasonable guide to who should be most careful here.
People with gastrointestinal issues may experience side effects such as nausea, vomiting, diarrhea, and abdominal cramps when taking 5-HTP [1]. These symptoms are often dose-dependent and can be more pronounced at higher doses. Therefore, individuals with sensitive digestive systems might find 5-HTP difficult to tolerate.
Furthermore, 5-HTP may impact cognitive functions. One study found that oral administration of 5-HTP impaired decision-making under ambiguity, though not under risk [11]. This suggests a potential influence on complex cognitive processes, which could be a concern for some individuals.
Pregnant or breastfeeding women should avoid 5-HTP due to a lack of sufficient safety data. The potential effects on fetal development or infant health are not well-established, making it prudent to err on the side of caution. Similarly, children should not be given 5-HTP without specific medical guidance due to insufficient research on its safety and efficacy in pediatric populations.
Potential Drug Interactions Beyond Antidepressants
The interaction of 5-HTP with other medications extends beyond antidepressants and triptans. Any medication that affects serotonin levels or central nervous system activity could potentially interact with 5-HTP. This includes some over-the-counter cough and cold remedies containing dextromethorphan, which can also affect serotonin pathways. That risk does not require an overdose to appear: a 52-year-old man stable on sertraline developed serotonin syndrome three days after starting a standard dextromethorphan-containing cough syrup at normal doses [12].
Herbal supplements that are known to influence mood or serotonin, such as St. John’s Wort, should also be avoided in combination with 5-HTP. St. John’s Wort is named among the herbal products that contribute to serotonin syndrome [4], and reviews of over-the-counter mood and sleep botanicals list serotonin syndrome alongside cytochrome P450 drug interactions as a recognized risk of the category [13]. The cumulative effect of multiple serotonin-enhancing substances can increase the risk of adverse reactions. Always disclose all medications and supplements, both prescription and over-the-counter, to a healthcare provider before starting 5-HTP.
Liver and Kidney Health Considerations
The body processes and eliminates supplements through various organs, including the liver and kidneys. While specific contraindications for 5-HTP use in severe liver or kidney disease are not well characterized in the published literature, it is generally prudent for individuals with compromised organ function to consult a healthcare provider before taking any new supplement. Impaired organ function could potentially alter the metabolism and excretion of 5-HTP, leading to higher levels in the body and an increased risk of side effects.
References
- 5-hydroxytryptophan. Alternative medicine review : a journal of clinical therapeutic, 1998
- 5-Hydroxytryptophan: a clinically-effective serotonin precursor. Alternative medicine review : a journal of clinical therapeutic, 1998
- Precipitants and clinical features of serotonin syndrome: a systematic review with patient-level analysis of published case reports and series. European journal of clinical pharmacology, 2026
- Serotonin syndrome: An often-neglected medical emergency. Journal of family & community medicine, 2024
- 5-Hydroxytryptophan (5-HTP): Natural Occurrence, Analysis, Biosynthesis, Biotechnology, Physiology and Toxicology. International journal of molecular sciences, 2020
- Serotonin syndrome-A focused review. Basic & clinical pharmacology & toxicology, 2023
- The safety of triptans in the treatment of patients with migraine. The American journal of medicine, 2002
- Mania following addition of hydroxytryptophan to monoamine oxidase inhibitor. General hospital psychiatry, 2012
- Clinical effects of L-5-hydroxytryptophan administration in chronic schizophrenic patients. Biological psychiatry, 1979
- Clinical risk factors and serotonin transporter gene variants associated with antidepressant-induced mania. The Journal of clinical psychiatry, 2015
- Oral administration of 5-hydroxytryptophan (5-HTP) impairs decision making under ambiguity but not under risk: evidence from the Iowa Gambling Task. Human psychopharmacology, 2010
- Serotonin syndrome induced by Bromfed DM in a patient on sertraline. SAGE open medical case reports, 2025
- Efficacy and Safety of Herbal Supplements with Anxiolytic, Antidepressant, and Sedative Action: A Review of Clinical Data and Toxicological Risks. Pharmaceuticals (Basel, Switzerland), 2026
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
